Cann Global Limited

ASX:CGB ISIN:AU0000038085

Cann Global Limited ASX:CGBCann Global Limited's (ASX:CGB) primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets.

Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and a management agreement with Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group.

The Group also retains an interest in its existing Bauxite Projects.

    

News

Cann Global Limited (ASX:CGB) Market Update

🕔7/12/2019 8:57:32 AM 1045

Cann Global Limited (ASX:CGB) is pleased to advise that the company is in the process of providing the ASX with all the paperwork confirming completion of all the transactions, completion of all the share issues, receipt of all the required escrow agreements, and the related required relisting documentation.

Read Full Article
###

0 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 374) (Last 30 Days: 545) (Since Published: 546) 

Markets ASX:CGB

Company Data

    Headquarters
  • 24 Birriga Rd
    Bellevue Hill NSW 2023
    Australia
  • Telephone
  • +61-2-8379-1832 
  • Principal Sector
  • Cannabis and Hemp 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.canngloballimited.com
  • E:
  • media@canngloballimited.com

Social Media